Expertise in
8
conditions

Jean-christophe C. Ianotto

Brest, FR 
Expertise in
8
conditions
Brest, FR 

Overview

Jean-christophe Ianotto practices practicing medicine in Brest, France.

Mr. Ianotto is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Myelofibrosis, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 117 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Brest, France
Other Locations
Paris, France
France
Lyon, France
Dijon, France
Fismes, France
CHU de Pontchaillou
Rennes, France
Angers, France
Bordeaux, France
Paul, France
Lens, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis
A Phase 2, Randomized, Open-Label, Multicenter Study to Evaluate Safety and Efficacy of Single Agent Selinexor Versus Treatment of Physician's Choice in Patients With Previously Treated Myelofibrosis
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Drug, Other
Study Drug: Selinexor
Study Phase: Phase 2
Analyse du caractère prédictif de l'échographie Ganglionnaire Pour le Diagnostic de bégninité ou malignité d'Une adénopathie Superficielle
Analyse du caractère prédictif de l'échographie Ganglionnaire Pour le Diagnostic de bégninité ou malignité d'Une adénopathie Superficielle
Enrollment Status: Withdrawn
Publish Date: June 26, 2026
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Tamibarotene Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, Adult Patients Selected for RARA-positive Higher-risk Myelodysplastic Syndrome (SELECT MDS-1)
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Tamibarotene Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, Adult Patients Selected for RARA-positive Higher-risk Myelodysplastic Syndrome (SELECT MDS-1)
Enrollment Status: Terminated
Publish Date: April 10, 2025
Intervention Type: Drug
Study Drugs: SY-1425+Azacitidine, Azacitidine
Study Phase: Phase 3
Pilot Study for the Development of a Non-invasive Diagnostic Score to Differentiate Between Essential Thrombocythemia, Premyelofibrosis and Myelofibrosis
Pilot Study for the Development of a Non-invasive Diagnostic Score to Differentiate Between Essential Thrombocythemia, Premyelofibrosis and Myelofibrosis
Enrollment Status: Completed
Publish Date: December 30, 2024
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms
Enrollment Status: Completed
Publish Date: February 21, 2021
Intervention Type: Drug
View 4 Less Clinical Trials

117 Total Publications

Use of Ruxolitinib in Pediatric Polycythemia Vera: Expanding Indications Beyond Adult Paradigms? A Case Report.
Use of Ruxolitinib in Pediatric Polycythemia Vera: Expanding Indications Beyond Adult Paradigms? A Case Report.
Journal: Pediatric blood & cancer
Published: July 03, 2026

Frequently Asked Questions about Jean-christophe C. Ianotto

Is Jean-christophe C. Ianotto a top-rated expert for Essential Thrombocythemia?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-christophe C. Ianotto is classified as an Elite expert for Essential Thrombocythemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-christophe C. Ianotto participate in research or clinical trials?

Yes. Jean-christophe C. Ianotto has published 117 articles and abstracts on conditions like Essential Thrombocythemia. You can view a list of Jean-christophe C. Ianotto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ianotto's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile